Title- Genomic landscape of squamous cell carcinoma- Different genetic pathways culminating in a common phenotype
- PMID: 33260028
- DOI: 10.1016/j.ctarc.2020.100238
Title- Genomic landscape of squamous cell carcinoma- Different genetic pathways culminating in a common phenotype
Abstract
Introduction: Squamous cell carcinomas (SqCCs) are the most common solid tumors in humans and are found across multiple organ systems. Although, integrated analysis of genetic alterations divulge similarities between SqCCs from various body sites, certain genes appear to be more frequently mutated in a given SqCC. These subtle differences may hold the key to determining the differentiation characteristics and predicting aggressiveness of tumors.
Materials and method: Fifty-four cases of SqCCs, in which the primary location of the tumor could be ascertained by clinical and radiological findings, were included in this study. Next generation sequencing data was analyzed for recurrent genetic abnormalities.
Results: Genetic alterations were found in 219 genes in the 54 cases studied. TP53 mutations were found to be more frequent in pulmonary SqCCs (86.5%) as compared to non-pulmonary SqCCs (58.8%) (p<0.05). NOTCH gene family mutations and CREBBP mutations were limited to non-pulmonary SqCC (p<0.005) and were mutated in 41.2% and 17.6% cases.
Conclusion: A detailed comparative analysis of the genetic alterations identified by sequencing identified higher frequency of TP53 mutations in lung SqCCs as compared to non-pulmonary SqCCs. NOTCH and CREBPP mutations were found to be absent in lung and head and neck SqCCs and more frequent in SqCCs from other locations.
Keywords: Crebbp; Next generation sequencing; Notch; Squamous cell carcinoma genetics; Tp53.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder.Int J Clin Exp Pathol. 2015 Jul 1;8(7):8143-58. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26339383 Free PMC article.
-
Comprehensive analysis of oncogenic mutations in lung squamous cell carcinoma with minor glandular component.Chest. 2014 Mar 1;145(3):473-479. doi: 10.1378/chest.12-2679. Chest. 2014. PMID: 24158231
-
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.Nat Genet. 2016 Jun;48(6):607-16. doi: 10.1038/ng.3564. Epub 2016 May 9. Nat Genet. 2016. PMID: 27158780 Free PMC article.
-
New developments in the treatment of squamous cell lung cancer.Curr Opin Oncol. 2014 Mar;26(2):152-8. doi: 10.1097/CCO.0000000000000049. Curr Opin Oncol. 2014. PMID: 24441504 Review.
-
Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.World J Gastroenterol. 2016 Feb 21;22(7):2284-93. doi: 10.3748/wjg.v22.i7.2284. World J Gastroenterol. 2016. PMID: 26900290 Free PMC article. Review.
Cited by
-
The Current Roadmap of Lung Cancer Biology, Genomics and Racial Disparity.Int J Mol Sci. 2025 Apr 17;26(8):3818. doi: 10.3390/ijms26083818. Int J Mol Sci. 2025. PMID: 40332491 Free PMC article. Review.
-
MicroRNA31 and MMP-1 contribute to the differentiated pathway of invasion -with enhanced epithelial-to-mesenchymal transition- in squamous cell carcinoma of the skin.Arch Dermatol Res. 2022 Oct;314(8):767-775. doi: 10.1007/s00403-021-02288-x. Epub 2021 Oct 13. Arch Dermatol Res. 2022. PMID: 34647185
-
Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor Entities.Cancers (Basel). 2024 Jun 30;16(13):2425. doi: 10.3390/cancers16132425. Cancers (Basel). 2024. PMID: 39001487 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous